An Opportunity For Patient Investors

While several large-cap names have enjoyed solid share-price performance for the year on the back of a near 10% year-to-date performance for the S&P-500 (SPY), returns have been quite bifurcated between small-caps and large-caps, and especially those small caps with sub $1.0 billion valuations. This is evidenced by the iShares Russell MicroCap Index Fund ETF…